Abstract
Objective: β2 receptor agonists can decrease uterine activity and increased endometrial blood flow (Akerlund and Andersson, 1976). On the other hand, decreased uterine contractions frequency at the time of embryo transfer is associated with increased implantation and pregnancy rates (Fanchin et al., 1998). Impaired perfusion of endometrial blood flow has an unfavourable reproductive outcome (Yang et al., 1999). The purpose of this study was to compare in a prospective randomized trial the use of two b2 receptor agonists (terbutaline and ritodrine) during the peri-implantation period in terms of the ICSI program outcome.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
